Inflammation

Items 171-180 of 368

per page
Set Descending Direction
  1. HMGB1 (human) (rec.) (His)
    CHI-HR-200HMGB1
    CHI-HR-200HMGB1-C02525 µg
    CHF 330.00
  2. HpARI (Alarmin Release Inhibitor) (rec.) (His)
    AG-40B-0178
    AG-40B-0178-C05050 µg
    CHF 360.00
    AG-40B-0178-30503 x 50 µg
    CHF 720.00
    HpARI (Alarmin Release Inhibitor) (rec.) (His)
  3. HpARI (CCP1/2) (rec.) (His)
    AG-40B-0201
    AG-40B-0201-C05050 µg
    CHF 440.00
    AG-40B-0201-30503 x 50 µg
    CHF 880.00
    HpARI (CCP1/2) (rec.) (His)
  4. IFN-γ (human) (rec.) (His)
    CHI-HR-200IFNG
    CHI-HR-200IFNG-C01010 µg
    CHF 130.00
    CHI-HR-200IFNG-C05050 µg
    CHF 370.00
  5. IGFL1 (human) (rec .)
    AG-40B-0244
    AG-40B-0244-C01010 µg
    CHF 380.00
    AG-40B-0244-30103 x 10 µg
    CHF 760.00
    IGFL1 (human) (rec .)
  6. IGFL3 (human) (rec.)
    AG-40B-0090
    AG-40B-0090-C01010 µg
    CHF 420.00
    AG-40B-0090-30103 x 10 µg
    CHF 840.00
    IGFL3 (human) (Prod. No. AG-40B-0090) binds to its receptor IGFLR1 (human):Fc (human) (Prod. No. AG-40B-0087). Method: IGFLR1 (human):Fc was coated on an ELISA plate at 1μg/ml overnight at room temperature. IGFL-3 (human) or a negative control, Ome
  7. IGFL4 (human) (rec.) (His)
    AG-40B-0251
    AG-40B-0251-C01010 µg
    CHF 380.00
    AG-40B-0251-30103 x 10 µg
    CHF 760.00
    IGFL4 (human) (rec.) (His)
  8. IGFLR1 (human):Fc (human) (rec.)
    AG-40B-0087
    AG-40B-0087-C05050 µg
    CHF 470.00
    IGFLR1 (human):Fc (human) (Prod. No. AG-40B-0087) binds to its ligand IGFL-3 (human) (Prod. No. AG-40B-0090). Method: IGFLR1 (human):Fc was coated on an ELISA plate at 1μg/ml overnight at room temperature. IGFL-3 (human) or a negative control
  9. IL-1α (human) (rec.)
    CHI-HF-20001A
    CHI-HF-20001A-C01010 µg
    CHF 250.00
  10. IL-1α (human) (rec.) (His)
    CHI-HR-20001A
    CHI-HR-20001A-C01010 µg
    CHF 210.00
    CHI-HR-20001A-C05050 µg
    CHF 560.00

Items 171-180 of 368

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.